Effect of interleukin-2 on long term infusion treatment regimen of ch14.18/CHO antibody on activity in relapsed/refractory neuroblastoma patients

Authors :: Ruth Ladenstein
Evelyne Janzek
Hans Loibner
Christin Eger
Holger N. Lode
Nikolai Siebert
Source :: Journal of Clinical Oncology. 34:10563-10563
Publication Year :: 2016
Publisher :: American Society of Clinical Oncology (ASCO), 2016.
Abstract: 10563Background: Long-term infusion (LTI) emerges as a promising new delivery method of ch14.18/CHO for relapsed/refractory neuroblastoma patients. The role of concomitant treatment with scIL2 is u...

Subjects :: Interleukin 2
Oncology
Cancer Research
medicine.medical_specialty
biology
business.industry
Treatment regimen
education
medicine.disease
Refractory
Concomitant
Internal medicine
Neuroblastoma
Relapsed refractory
biology.protein
Medicine
Antibody
business
medicine.drug

Full Text Access

Tools